Primary Cutaneous Lymphoma — Trials

Primary Cutaneous Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

353 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 67
Recruiting: 32
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: Mayo Clinic
Termination share: 38.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (77)

clinicaltrialsPublishedShowing 51–59 of 59 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00060112	Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma	terminated	Phase 1	15	National Cancer Institute (NCI)NIH	1	Jan 25, 2013	clinicaltrials
NCT00005982	506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell Lymphoma	terminated	Phase 2	35	National Cancer Institute (NCI)NIH	1	Jan 23, 2013	clinicaltrials